Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Change in Accured Expenses (2023 - 2025)

Historic Change in Accured Expenses for Fractyl Health (GUTS) over the last 3 years, with Q3 2025 value amounting to -$811000.0.

  • Fractyl Health's Change in Accured Expenses fell 14108.41% to -$811000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 593.59%. This contributed to the annual value of $5.7 million for FY2024, which is 2287.55% down from last year.
  • As of Q3 2025, Fractyl Health's Change in Accured Expenses stood at -$811000.0, which was down 14108.41% from $614000.0 recorded in Q2 2025.
  • In the past 5 years, Fractyl Health's Change in Accured Expenses registered a high of $2.9 million during Q1 2024, and its lowest value of -$1.8 million during Q2 2024.
  • Over the past 3 years, Fractyl Health's median Change in Accured Expenses value was $614000.0 (recorded in 2025), while the average stood at $616363.6.
  • In the last 5 years, Fractyl Health's Change in Accured Expenses skyrocketed by 243076.92% in 2024 and then crashed by 14108.41% in 2025.
  • Over the past 3 years, Fractyl Health's Change in Accured Expenses (Quarter) stood at $367000.0 in 2023, then surged by 613.35% to $2.6 million in 2024, then tumbled by 130.98% to -$811000.0 in 2025.
  • Its Change in Accured Expenses stands at -$811000.0 for Q3 2025, versus $614000.0 for Q2 2025 and $780000.0 for Q1 2025.